Skip to main content

Security report for moleculeconsultancy.com

Molecule Consultancy · Healthcare · Denmark

High risk. 3 critical or high findings in Network security and SSL/TLS.

Security score

49/100

Risk levelHigh

0–100, higher is better. How it is calculated

Molecule Consultancy is a Danish consultancy firm specializing in life science and healthcare communication. They serve a broad range of healthcare clients, from large pharmaceutical companies to biotech startups, offering services including strategy, market access, public affairs, digital and social media engagement, corporate communication, medical communication, medical marketing, patient engagement, and PR campaigns. The company positions itself as a trusted advisor with a strong ethical foundation and a commitment to sustainability within the healthcare sector. Their website reflects a professional and consistent brand image with clear service offerings and contact information. Technically, the website is built on WordPress and leverages modern web technologies such as jQuery, Google Analytics, Google reCAPTCHA, and Cloudflare for CDN and security. The site is mobile-optimized, SEO-friendly, and includes a comprehensive cookie consent mechanism compliant with GDPR. Email addresses are obfuscated to reduce spam, and social media presence is established primarily on LinkedIn and Twitter. From a security perspective, the site enforces HTTPS and uses reCAPTCHA for form protection. However, it lacks explicit security headers and a published security or incident response policy. No vulnerabilities or exposed sensitive data were detected in the content. The absence of WHOIS data for the domain is a concern for domain legitimacy and trustworthiness, though the website content and professional presentation mitigate some of this risk. Overall, the site demonstrates a good balance of content quality, technical implementation, security posture, privacy compliance, and business credibility, scoring an overall AI rating of 78 out of 100. Strategic recommendations include improving security headers, publishing explicit privacy and security policies, and verifying domain registration details to enhance trust.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • Critical

      Critical Service Exposed: MySQL

      Port 3306 (MySQL) is publicly accessible - MySQL - Database server

      What to do: Immediately restrict access to MySQL using firewall or VPN

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection
    • High

      High-Risk Service Exposed: FTP

      Port 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer

      What to do: Consider restricting access to FTP or implementing strong authentication

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection
  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching moleculeconsultancy.com

This scan found 17 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
82
Security headers
80
Email security
85
DNS health
70
Network security
0
GDPR outside view
88
Average
68
After the cap
49

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet · found on this site
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Molecule Consultancy operates in the healthcare sector, targeting pharmaceutical companies, biotech startups, and healthcare stakeholders in Denmark and potentially broader markets. Their competitive advantage lies in their specialized expertise in healthcare communication across multiple disciplines, including medical marketing, public affairs, and patient engagement. The business model is consultancy-based, generating revenue through service contracts with healthcare clients. The company demonstrates growth through active engagement in events like Molecule Health Talks and maintains a professional partnership ecosystem, including ethical compliance with industry standards. Their digital presence supports lead generation via mailing lists and social media engagement. Strategic observations suggest a focus on sustainability and ethical communication as differentiators in a regulated industry.

Security posture

The website exhibits a mature security posture with HTTPS enforced and the use of Google reCAPTCHA to protect forms from automated abuse. Cookie consent is managed comprehensively with granular user controls, supporting GDPR compliance. Email obfuscation reduces spam risk. However, the absence of key security headers such as Content-Security-Policy and X-Frame-Options is a gap that could expose the site to certain web-based attacks. There is no visible security.txt or incident response information, which limits transparency for vulnerability reporting. The missing WHOIS data for the domain raises concerns about domain legitimacy and potential risks related to domain ownership. Overall, the security maturity is good but could be improved with enhanced headers and published security policies.

Recommendations

  1. Implement and enforce security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to mitigate common web vulnerabilities.
  2. Publish a clear privacy policy page separate from the cookie policy to improve transparency and compliance.
  3. Establish and publish a security.txt file and incident response policy to facilitate vulnerability disclosure and improve trust.
  4. Verify and update WHOIS domain registration information to ensure domain legitimacy and reduce risk of domain-related issues.
  5. Enhance accessibility features to meet higher standards and improve user experience for all visitors.

Contact details published on the site

Addresses
Legal name
Molecule Consultancy A/S
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Molecule Consultancy
Description
Konsulenthus specialiseret i life science og sundhed. Rådgivere for en bred vifte af healthcare kunder, fra big pharma til biotech startups.
Key services
Analyse & strategi, Market access, Public affairs, Digital & social, Corporate kommunikation, Medicinsk kommunikation, Medical marketing, Patienter & pårørende, PR & kampagner
Content quality
good
Branding
consistent

Technology

Stack
WordPress, jQuery, Google Analytics, Google reCAPTCHA, Slick Slider, Cloudflare (for CDN and security)
Platforms
WordPress CMS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent banner with granular controls
  • Use of Google reCAPTCHA for form protection
  • Email addresses obfuscated via JavaScript encoding

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
MailChimp (email marketing), Google reCAPTCHA
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content
  2. Cookie consent mechanism is comprehensive and GDPR compliant
  3. No explicit privacy policy page found, but cookie policy is detailed
  4. Contact information is clearly presented with multiple channels
  5. WHOIS data missing, which is a concern for domain legitimacy
  6. Use of modern web technologies and analytics tools
  7. No signs of WAF or security blocking
  8. Email addresses are obfuscated to reduce spam
  9. Social media presence on LinkedIn and Twitter
  10. No visible security.txt or incident response info
Technical notes

Notes

The website is built on WordPress CMS with a modern tech stack including jQuery, Slick Slider for UI components, and Google Analytics for traffic analysis. Hosting and CDN services appear to be provided by Cloudflare, enhancing performance and security. The site is mobile responsive and SEO optimized with proper meta tags and structured data (JSON-LD) for enhanced search engine visibility. Performance is moderate with asynchronous loading of analytics and reCAPTCHA scripts. Email addresses are protected using JavaScript encoding to prevent scraping. The site uses a cookie consent banner powered by Cookie Information, supporting GDPR compliance. Technical risks include missing security headers and reliance on multiple third-party scripts which require regular auditing.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with moleculeconsultancy.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review moleculeconsultancy.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.